Recently, an interesting study was published about a vaccination against a once fashionable virus that has been forgotten by many:

The study was done on a huge sample of people and showed great harm, which I wrote/talked about back in 2021.

Let's look at the findings of the study together, and then watch my little slideshow of the "experts" (mental geniuses 🤣) of Instagram/clinics/organizations who called me and other reasonable people names during those "dark" times...

Unfortunately, they all continue their stupid deeds in the field of public health. 🤦‍♂️

Theses from the study itself:

The Global COVID Vaccine Safety (GCoVS) project, established in 2021 as part of the multinational Global Vaccine Data Network™ (GVDN®), facilitates comprehensive assessment of vaccine safety. This study aimed to assess the risk of adverse events of particular concern (AESI) following COVID-19 vaccination at 10 sites in eight countries.

Methods

Using a common protocol, this observational cohort study compared observed and expected rates of 13 selected AESIs across neurological, hematological, and cardiac outcomes. Expected rates were generated by participating institutions using pre-COVID-19 vaccination medical records stratified by age and sex. Observed rates were generated from the same medical datasets used since the COVID-19 vaccination program was rolled out. AESIs occurring within 42 days of mRNA (BNT162b2 and mRNA-1273) and adenovirus vector vaccine (ChAdOx1) vaccination were included in the primary analysis. Risks were estimated using observed-to-expected (OE) ratios with 95% confidence intervals. Priority potential safety signals were those with a lower bound of the 95% confidence interval (LBCI) greater than 1.5.

Results obtained

A total of 99,068,901 vaccinated individuals were included. A total of 183,559,462 doses of BNT162b2, 36,178,442 doses of mRNA-1273, and 23,093,399 doses of ChAdOx1 were administered at participating centers during the study period. The risk periods after homologous vaccination regimens totaled 23,168,335 person-years of observation. OE ratios with LBCI > 1.5 were observed for Guillain-Barré syndrome (2.49, 95% CI: 2.15, 2.87) and cerebral venous sinus thrombosis (3.23, 95% CI: 2.51, 4.09) after the first dose of ChAdOx1 vaccine. For acute disseminated encephalomyelitis, the OE ratio was 3.78 (95% CI: 1.52, 7.78) after the first dose of mRNA-1273 vaccine. The OE ratios for myocarditis and pericarditis after BNT162b2, mRNA-1273, and ChAdOx1 were significantly increased at LBCI > 1.5.

Conclusion

This multi-country analysis confirmed the previously identified safety signals for myocarditis, pericarditis, Guillain-Barré syndrome, and cerebral venous sinus thrombosis. Other potential safety signals were identified that require further investigation.

Now let's look together at what the "experts" once wrote:

Link to the study here: https://www.sciencedirect.com/science/article/pii/S0264410X24001270?via%3Dihub

From DrMoro

Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Dieses Formular wird nicht unterstützt
Aus Sicherheitsgründen solltest du keine Informationen über diese Art von Formular senden, während du Google Translate verwendest.
OkTo Original URL